Ideal Power–s Power Conversion System Selected by Sonnenbatterie for Their Commercial Energy Storage Solutions

Ideal Power–s Power Conversion System Selected by Sonnenbatterie for Their Commercial Energy Storage Solutions

LOS ANGELES, CA and AUSTIN, TX — (Marketwired) — 08/06/15 — Ideal Power Inc., (NASDAQ: IPWR), a developer of innovative power conversion technologies, and Sonnenbatterie, Europe–s leading smart energy storage provider, announced today that Sonnenbatterie has selected Ideal Power–s power conversion systems, utilizing its award-winning Power Packet Switching Architecture (PPSA), for integration with the commercial Sonnenbatterie system. Sonnenbatterie also has placed initial product orders w

Viavi to Revise Earnings Call Time for Fiscal Fourth Quarter and Year-End 2015 Financial Results

Viavi to Revise Earnings Call Time for Fiscal Fourth Quarter and Year-End 2015 Financial Results

MILPITAS, CA — (Marketwired) — 08/05/15 — Viavi Solutions Inc. ("Viavi") (NASDAQ: VIAV), formerly JDSU, is rescheduling its earnings call for 1:15pm PT/4:15pm ET on August 11, 2015 to discuss its fiscal fourth quarter and year-end 2015 financial results for the period ended June 27, 2015. Previously, this call had been scheduled for 2:30pm PT.Lumentum, formerly JDSU–s Communications and Commercial Optical Products business segment, will host a call to discuss fiscal first quarter

IEC Announces Fiscal 2015 Third Quarter Revenue Growth

IEC Announces Fiscal 2015 Third Quarter Revenue Growth

NEWARK, NY — (Marketwired) — 08/05/15 — IEC Electronics Corp, (NYSE MKT: IEC) today announced results for the third quarter and nine months ended June 26, 2015.For the third quarter of fiscal year 2015, the Company recorded revenue of $34.4 million, an increase of 4% as compared to revenue of $33 million during the third quarter of the last fiscal year and an increase of 5% sequentially compared to the second quarter of 2015. Gross profit margin for the third quarter improved to 13.7% as com

BIOTRONIK Announces Start of First Study to Assess Relevance of Defibrillator Back-Up after CRT-D Replacement

08.2015 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that the first patient has been enrolled in the BioCONTINUE clinical trial (BIOtronik study to assess the CONTINUation of Existing risk of ventricular arrhythmias after CRT-D replacement). BioCONTINUE is the first study to investigate the relevance of defibrillator back-up following first device replacement in a heart failure (HF) patient population with a primary indication for a cardiac resynchron